Jean de Gunzburg
This presentation was part of the Biotech Showcase at the Pharmabiotic Research Institute’s Annual Event, Pharmabiotics Conference & Partnering. The PRI is Europe’s leading microbiome regulatory science expertise center and was founded in 2010 to support the development of microbiome-based medicines for the EU market, for the benefit of patients. It applies a unique ‘Share & Learn’ approach to overcome the complex and various regulatory challenges faced by the relevant stakeholders. Its overall mission is to facilitate the conversation between European regulators and Microbiome medicinal product developers and their partners, and to become the key network of stakeholders driving the new therapeutic and diagnostic innovation in the field of microbiome science.
